AzTrials
AzTrials

Pregnancy RelatedNCT04686240

Doppler Ultrasonographic Assessment of Fetal Internal Thoracic Artery Indexes

An observational study of Pregnancy Related and Fetal; Circulation, run by Ankara City Hospital Bilkent.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to assess the feasibility of visualizing the internal thoracic artery (ITA), establishing the normogram for ITA pulsatility index (PI), resistance index (RI) and acceleration/ejection time (AT/ET) at 24-32 weeks. Read more about this study

Who is it for?
Ages 17 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy Related, Fetal; Circulation
How many people
150 participants
Where
No sites listed yet
Study dates
Jan 2021to Jun 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Study population: healthy fetuses between 24th and 32nd gestational weeks

Who may be able to join

  • singleton pregnancy
  • having no fetal anomalies
  • healthy pregnant women age >17 and <45 years
  • between 24th-32nd gestational weeks

Who cannot join

  • fetuses with congenital aneuploidy or structural malformation
  • underlying chronic diseases
  • pregnant women complicated with gestational diabetes, Type 1-2 DM, hypertension (pregnancy-induced; chronic; preeclampsia), malignancy
  • pregnancy complicated with preterm premature rupture of membranes, preterm labour, fetal growth restriction and another obstetric complication

Trial locations and contacts

No sites are listed yet.

betül yakıştıran, MD contact

+905464296321

btlengin@gmail.com

aykan yücel, professor contact

+905323851110

aykanyucel@gmail.com

About this study

The aim of this study is to assess the feasibility of visualizing the internal thoracic artery (ITA), establishing the normogram for ITA pulsatility index (PI), resistance index (RI) and acceleration/ejection time (AT/ET) at 24-32 weeks.

Read the detailed description

Background: The internal thoracic artery arises from the subclavian artery as the first branch. It travels downward on the inside of the rib cage and then gives off six main branches; mediastinal, thymic, pericardiacophrenic, sternal, perforating and intercostal branches.

In literature, there are so many articles that have been focused on thymus size in pregnancies complicated with diabetes mellitus, fetal growth restriction, preterm rupture of membranes and so on. To the best of our knowledge, there is no paper about fetal ITA whose branch are feeding vessel of thymus and ITA Doppler velocity. The arteries supplying the thymus are branches of the internal thoracic, and inferior thyroid arteries. As far as it has been known, growing of a tissue depends on increased blood flow. Before detecting possible blood-flow changes in fetuses complicated with great obstetrics patologies, the investigators should obtain normal values of ITA Doppler velocity.

Medical subject headings
Persistent Fetal Circulation Syndrome

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Doppler indices for internal thoracic artery

    Doppler indices (pulsatility index, resistance index, acceleration and ejection time)

    Measured: Between 24th and 32nd gestational weeks

  2. assessment of fetal thymus size

    volume and perimeter and transvers diameter

    Measured: Between 24th and 32nd gestational weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2020
  2. Study startJan 2021 (estimated)
  3. Primary completionApr 2021 (estimated)
  4. Study completionJun 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04686240
Sponsor's protocol ID
internalthoracicarterydoppler
Status last verified
Dec 2020
First submitted
22 Dec 2020
Last updated
28 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pregnancy Related and Fetal; Circulation, run by Ankara City Hospital Bilkent.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact betül yakıştıran, MD (+905464296321, btlengin@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Doppler indices for internal thoracic artery (time frame: Between 24th and 32nd gestational weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in